FDA Moves Forward With Marijuana-Based Drug To Fight Childhood Epilepsy

The Food and Drug Administration has granted orphan drug designation for a cannabis-based drug developed to treat childhood-onset epilepsy, GW Pharmaceuticals announced last week.